a b s t r a c t
Despite dramatic improvement in cardiopulmonary resuscitation (CPR) and other techniques for cardiac arrest (CA), the majority of survivors continue to show signs of decreased memory or executive cognitive function. Such memory impairment may be due to hippocampal CA1 neuronal death, which is delayed by several days after CA/CPR. Classical microgliosis in the CA1 region may contribute to neuronal death, yet the role of a key activation receptor Toll Like Receptor 4 (TLR4) has not been previously investigated for such neuronal death after CA/CPR. We show that (+)-naltrexone was neuroprotective after CA/CPR. TLR4 blockade was associated with decreased expression of markers for microglial/macrophage activation and T cell and B cell infiltration, as well as decreased pro-inflammatory cytokine levels. Notably, IL-10 expression was elevated in response to CA/CPR, but was not attenuated by (+)-naltrexone, suggesting that the local monocyte/microglial phenotype had shifted towards alternative activation. This was confirmed by elevated expression of Arginase-1, and decreased expression of NFjB p65 subunit. Thus, (+)-naltrexone and other TLR4 antagonists may represent a novel therapeutic strategy to alleviate the substantial burden of memory or executive cognitive function impairment after CA/CPR. Ó 2015 Elsevier Inc. All rights reserved.
Introduction
Cardiac arrest (CA) is a leading cause of mortality in developed nations (Go et al., 2014) . Despite dramatic improvement in cardiopulmonary resuscitation (CPR) techniques and the widespread adoption of hypothermia as a treatment option, the majority of survivors continue to show signs of decreased memory or executive cognitive function, which is a cause of significant and sustained disability (Allen and Buckberg, 2012; Cronberg et al., 2009; Mateen et al., 2011) . Such memory impairment is believed to be caused by death of hippocampal CA1 neurons, which are especially sensitive to transient global ischemia (Allen and Buckberg, 2012; Garcia, 1988; Garcia and Anderson, 1989) . Since neuronal death is delayed by several days after CA/CPR (Bottiger et al., 1998) , there is a unique window of opportunity for therapeutic intervention. Despite the fact that trained medical personnel are present during this window, there are no routine interventions to prevent delayed neuronal death after CA/CPR.
Microglia are the tissue specific macrophages of the central nervous system that rapidly respond to insult, sometimes creating a neurotoxic environment (Kettenmann et al., 2011) . Microgliosis may occur in response to a broad array of challenges, including ischemia (Kettenmann et al., 2011) , and markers of microgliosis are increased in the CA1 region of the hippocampus after CA/CPR (Norman et al., 2011; Wang et al., 2013a) . Attenuation of microgliosis and the neurotoxic products of microglia is generally associated with neuroprotection after global ischemia (Neigh et al., 2009; Takeuchi et al., 2008; Tang et al., 2010; Wang et al., 2013a; Webster et al., 2013; Zhang et al., 2012) . Moreover, induction of interleukin 10 (IL-10) producing microglia (alternatively activated microglia) (Locati et al., 2013) is also neuroprotective for CA1 hippocampal neurons after CA/CPR (Wang et al., 2013a) . Therefore, classical microgliosis may contribute to neuronal death
